Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Jarvis

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Journal of Neural Transmission|January 1, 1988
Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blockerW J Brooks, M F Jarvis, G C Wagner
Neuropharmacology|May 1, 1986
Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ionG C Wagner, R M Carelli, M F Jarvis
Current Pharmaceutical Design|April 10, 1999
Adenosine kinase inhibitorsE A Kowaluk, S S Bhagwat, M F Jarvis
European Journal of Pharmacology|February 5, 1999
An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic painJ J Lynch, M F Jarvis, E A Kowaluk
European Journal of Pharmacology|August 25, 1992
The angiotensin hexapeptide 3-8 fragment potently inhibits [125I]angiotensin II binding to non-AT1 or -AT2 recognition sites in bovine adrenal cortexM F Jarvis, G W Gessner, C Q Ly
Research Communications in Chemical Pathology and Pharmacology|February 1, 1985
Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in ratsG C Wagner, R M Carelli, M F Jarvis
Synapse (New York, N.Y.)|October 1, 1991
Chronic theophylline treatment increases adenosine A1, but not A2, receptor binding in the rat brain: an autoradiographic studyC R Lupica, R F Berman, M F Jarvis
Journal of Neurochemistry|February 1, 1987
Characterization of adenosine receptors in the PC12 pheochromocytoma cell line using radioligand binding: evidence for A-2 selectivityM Williams, M Abreu, M F Jarvis, et al.
Molecular Pharmacology|January 1, 1991
Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortexM F Jarvis, M Williams, U H Do, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN)R H Jackson, M M Morrissey, M A Sills, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Journal of Neural Transmission|January 1, 1988
Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blockerW J Brooks, M F Jarvis, G C Wagner
Neuropharmacology|May 1, 1986
Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ionG C Wagner, R M Carelli, M F Jarvis
Current Pharmaceutical Design|April 10, 1999
Adenosine kinase inhibitorsE A Kowaluk, S S Bhagwat, M F Jarvis
European Journal of Pharmacology|February 5, 1999
An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic painJ J Lynch, M F Jarvis, E A Kowaluk
European Journal of Pharmacology|August 25, 1992
The angiotensin hexapeptide 3-8 fragment potently inhibits [125I]angiotensin II binding to non-AT1 or -AT2 recognition sites in bovine adrenal cortexM F Jarvis, G W Gessner, C Q Ly
Research Communications in Chemical Pathology and Pharmacology|February 1, 1985
Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in ratsG C Wagner, R M Carelli, M F Jarvis
Synapse (New York, N.Y.)|October 1, 1991
Chronic theophylline treatment increases adenosine A1, but not A2, receptor binding in the rat brain: an autoradiographic studyC R Lupica, R F Berman, M F Jarvis
Journal of Neurochemistry|February 1, 1987
Characterization of adenosine receptors in the PC12 pheochromocytoma cell line using radioligand binding: evidence for A-2 selectivityM Williams, M Abreu, M F Jarvis, et al.
Molecular Pharmacology|January 1, 1991
Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortexM F Jarvis, M Williams, U H Do, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN)R H Jackson, M M Morrissey, M A Sills, et al.
Pageof 8